Učitavanje...
DRES-02. CILIARY PROTEIN ARL13B PROMOTES CHEMORESISTANCE BY MODULATE GLIOBLASTOMA PURINE BIOSYNTHESIS
Glioblastoma (GBM) carries with it an almost 100% recurrence rate due to development of resistance to all conventional therapies. Our lab has demonstrated ARL13B, an ADP-ribosylation factor-like protein critical for cilia formation, plays an important role in promoting resistance to temozolomide (TM...
Spremljeno u:
| Izdano u: | Neuro Oncol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216376/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.309 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|